Cargando…

A two-stage Bayesian method for estimating accuracy and disease prevalence for two dependent dichotomous screening tests when the status of individuals who are negative on both tests is unverified

BACKGROUND: Estimating the disease prevalence and test accuracy (sensitivity and specificity) for two dependent screening tests when the status of individuals who are negative on both tests is unverified represents a considerable challenge, as the disease rates for individuals negative on both tests...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jin, Chen, Feng, Yu, Hao, Zeng, Ping, Liu, Liya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193534/
https://www.ncbi.nlm.nih.gov/pubmed/25245321
http://dx.doi.org/10.1186/1471-2288-14-110
_version_ 1782338992375595008
author Liu, Jin
Chen, Feng
Yu, Hao
Zeng, Ping
Liu, Liya
author_facet Liu, Jin
Chen, Feng
Yu, Hao
Zeng, Ping
Liu, Liya
author_sort Liu, Jin
collection PubMed
description BACKGROUND: Estimating the disease prevalence and test accuracy (sensitivity and specificity) for two dependent screening tests when the status of individuals who are negative on both tests is unverified represents a considerable challenge, as the disease rates for individuals negative on both tests are not identifiable without additional assumptions. METHODS: This article presents a unified framework for handling this non-identifiability problem using two-step hierarchical informative prior on the sensitivities by two-stage Bayesian modeling with the characterized by joint testing strategies based on the inherent attribute of screening/diagnostic tests. We assign a diffuse and less risky two-step hierarchical informative uniform prior to the sensitivities while assigning a uniform (0,1) prior distribution to the specificities and prevalence. Strategies for model evaluation, general global evaluations, and individual cell checking are presented. Simulations are conducted under various scenarios to evaluate the performance of the proposed method. Applications to real data are also presented to illustrate the potential impact and benefit of the proposed method. RESULTS: Our results indicate that when the priors of sensitivities are assigned as appropriate two-step hierarchical informative priors, or even in the absence of the priors for the specificities and prevalence, the parameters involved in this study can still be estimated well. The advantages and limitations of this method in solving such problems are discussed and compared with other two-stage methods. CONCLUSIONS: We developed a two-stage Bayesian method for two dependent dichotomous screening tests with unverified individuals who are negative on both tests, and addressed the ad hoc model evaluation and checking procedures. The method can be understood easily and used conveniently by non-statisticians. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2288-14-110) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4193534
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41935342014-10-11 A two-stage Bayesian method for estimating accuracy and disease prevalence for two dependent dichotomous screening tests when the status of individuals who are negative on both tests is unverified Liu, Jin Chen, Feng Yu, Hao Zeng, Ping Liu, Liya BMC Med Res Methodol Research Article BACKGROUND: Estimating the disease prevalence and test accuracy (sensitivity and specificity) for two dependent screening tests when the status of individuals who are negative on both tests is unverified represents a considerable challenge, as the disease rates for individuals negative on both tests are not identifiable without additional assumptions. METHODS: This article presents a unified framework for handling this non-identifiability problem using two-step hierarchical informative prior on the sensitivities by two-stage Bayesian modeling with the characterized by joint testing strategies based on the inherent attribute of screening/diagnostic tests. We assign a diffuse and less risky two-step hierarchical informative uniform prior to the sensitivities while assigning a uniform (0,1) prior distribution to the specificities and prevalence. Strategies for model evaluation, general global evaluations, and individual cell checking are presented. Simulations are conducted under various scenarios to evaluate the performance of the proposed method. Applications to real data are also presented to illustrate the potential impact and benefit of the proposed method. RESULTS: Our results indicate that when the priors of sensitivities are assigned as appropriate two-step hierarchical informative priors, or even in the absence of the priors for the specificities and prevalence, the parameters involved in this study can still be estimated well. The advantages and limitations of this method in solving such problems are discussed and compared with other two-stage methods. CONCLUSIONS: We developed a two-stage Bayesian method for two dependent dichotomous screening tests with unverified individuals who are negative on both tests, and addressed the ad hoc model evaluation and checking procedures. The method can be understood easily and used conveniently by non-statisticians. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2288-14-110) contains supplementary material, which is available to authorized users. BioMed Central 2014-09-23 /pmc/articles/PMC4193534/ /pubmed/25245321 http://dx.doi.org/10.1186/1471-2288-14-110 Text en © Liu et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Liu, Jin
Chen, Feng
Yu, Hao
Zeng, Ping
Liu, Liya
A two-stage Bayesian method for estimating accuracy and disease prevalence for two dependent dichotomous screening tests when the status of individuals who are negative on both tests is unverified
title A two-stage Bayesian method for estimating accuracy and disease prevalence for two dependent dichotomous screening tests when the status of individuals who are negative on both tests is unverified
title_full A two-stage Bayesian method for estimating accuracy and disease prevalence for two dependent dichotomous screening tests when the status of individuals who are negative on both tests is unverified
title_fullStr A two-stage Bayesian method for estimating accuracy and disease prevalence for two dependent dichotomous screening tests when the status of individuals who are negative on both tests is unverified
title_full_unstemmed A two-stage Bayesian method for estimating accuracy and disease prevalence for two dependent dichotomous screening tests when the status of individuals who are negative on both tests is unverified
title_short A two-stage Bayesian method for estimating accuracy and disease prevalence for two dependent dichotomous screening tests when the status of individuals who are negative on both tests is unverified
title_sort two-stage bayesian method for estimating accuracy and disease prevalence for two dependent dichotomous screening tests when the status of individuals who are negative on both tests is unverified
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193534/
https://www.ncbi.nlm.nih.gov/pubmed/25245321
http://dx.doi.org/10.1186/1471-2288-14-110
work_keys_str_mv AT liujin atwostagebayesianmethodforestimatingaccuracyanddiseaseprevalencefortwodependentdichotomousscreeningtestswhenthestatusofindividualswhoarenegativeonbothtestsisunverified
AT chenfeng atwostagebayesianmethodforestimatingaccuracyanddiseaseprevalencefortwodependentdichotomousscreeningtestswhenthestatusofindividualswhoarenegativeonbothtestsisunverified
AT yuhao atwostagebayesianmethodforestimatingaccuracyanddiseaseprevalencefortwodependentdichotomousscreeningtestswhenthestatusofindividualswhoarenegativeonbothtestsisunverified
AT zengping atwostagebayesianmethodforestimatingaccuracyanddiseaseprevalencefortwodependentdichotomousscreeningtestswhenthestatusofindividualswhoarenegativeonbothtestsisunverified
AT liuliya atwostagebayesianmethodforestimatingaccuracyanddiseaseprevalencefortwodependentdichotomousscreeningtestswhenthestatusofindividualswhoarenegativeonbothtestsisunverified
AT liujin twostagebayesianmethodforestimatingaccuracyanddiseaseprevalencefortwodependentdichotomousscreeningtestswhenthestatusofindividualswhoarenegativeonbothtestsisunverified
AT chenfeng twostagebayesianmethodforestimatingaccuracyanddiseaseprevalencefortwodependentdichotomousscreeningtestswhenthestatusofindividualswhoarenegativeonbothtestsisunverified
AT yuhao twostagebayesianmethodforestimatingaccuracyanddiseaseprevalencefortwodependentdichotomousscreeningtestswhenthestatusofindividualswhoarenegativeonbothtestsisunverified
AT zengping twostagebayesianmethodforestimatingaccuracyanddiseaseprevalencefortwodependentdichotomousscreeningtestswhenthestatusofindividualswhoarenegativeonbothtestsisunverified
AT liuliya twostagebayesianmethodforestimatingaccuracyanddiseaseprevalencefortwodependentdichotomousscreeningtestswhenthestatusofindividualswhoarenegativeonbothtestsisunverified